In HCC cells, LY2109761 prevents HCC cell migration and invasion by upregulating E-cadherin [178] and can also exert antitumor activity by inhibiting HCC neoangiogenesis [179]. This evidence concerns the gene CDH1 and hepatocellular carcinoma.